Streetwise Reports' Article Archives — Current Month (2)
Massachusetts Biotech Plummets as Skin Cancer Trial Fails (12/05/2023)
In recent news, Massachusetts clinical-stage biotechnology company Replimune Group Inc. revealed its latest clinical trial did not meet the endpoints needed to call it a success. With this, the stock has plummeted.
Pharma Co.'s Partnership a Key Validation (12/04/2023)
Recently, Arcus Biosciences Inc. announced a partnership with Exelixis Inc., which may be the key to validating the company, noted WedBush analysts in a December 4 report.
More Archives
2023Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan
2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
